Image courtesy of LivaNova PLC
November 4, 2015 — LivaNova PLC, formerly Sorin Group, launched Platinum, a new range of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds).
Platinum offers superior longevity thanks to technology that ensures extremely low electrical intrinsic consumption. In standard functioning conditions, the service life is projected to last over 14 years for the single-chamber ICD model, over 13 years for the dual-chamber ICD model and over 10 years for CRT-D devices.
More than 60 percent of patients are under 70 years of age at the time of their first implant, and more than one-third will require at least one replacement due to battery depletion. Replacement procedures are associated with twice as many surgical re-interventions as compared to de-novo procedures due to increased rates of complications, such as infections. The mortality rate in patients with an infection reaches 16.9 percent at one year and 27.5 percent at three years.
The longevity of Platinum aims to limit the number of device replacements, minimizing the risks that are inherent in replacement surgeries. That longevity has been achieved without compromising the size of the device: Platinum’s size ranges from 31cc to 33cc, and the ErgoformM design of the can, with its rounded shape and smooth edges, was designed to facilitate the implant procedure and improve patient comfort.
Platinum devices also feature proven therapeutic functions such as the PARAD+ arrhythmia discrimination algorithm; SafeR, a pacing mode which preserves natural heart conduction; and SonR, a hemodynamic sensor which automatically optimizes CRT settings.
For more information: www.livanova.com